Asia Pacific Newborn Screening Market Forecast to 2030

According to The Research Team’ research, the Asia Pacific newborn screening market was valued at US$ 270.13 in 2022 and is expected to reach US$ 602.14 million by 2030, registering a CAGR of 10.5% from 2022 to 2030. Genetic screening of newborns and rising burden of congenital diseases are among the critical factors attributed to the Asia Pacific newborn screening market expansion.

Congenital diseases can lead to lifelong health challenges if not detected and managed early. These diseases can contribute to long-term disability, significantly affecting families, individuals, healthcare systems, and societies. The WHO estimates that 240,000 newborns worldwide succumb to death each year within 28 days of birth due to these diseases. An additional 170,000 children die between the age of 1 month and 5 years due to congenital diseases. A growing understanding of the genetic basis of many congenital diseases is one of the several factors contributing to the increasing burden of these conditions. Advancements in genomics and genetic testing have enabled healthcare providers to identify a broader range of genetic mutations and conditions in newborns. This expanded knowledge has highlighted the importance of early diagnosis through newborn screening to initiate timely interventions and treatments.

Changing demographics such as maternal age, environmental exposures, and altering lifestyle habits increase the risk of congenital conditions in newborns. Moreover, the number of births occurring every day is on the rise due to the burgeoning global population, resulting in an expanding pool of infants that can be at risk of congenital diseases. In addition, healthcare systems and policymakers recognize the long-term benefits of early disease detection. They increasingly incorporate newborn screening into routine healthcare protocols and insurance coverage, further stimulating market growth. The rising burden of congenital diseases is a significant driver behind the growth of the newborn screening market.

On the contrary, lack of uniformity in newborn screening policies and practices hampers the growth Asia Pacific newborn screening market.

Based on product type, the Asia Pacific newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held 73.9% share of the Asia Pacific newborn screening market in 2022, amassing US$ 199.56 million. It is projected to garner US$ 473.69 million by 2030 to expand at 11.4% CAGR during 2022-2030. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the Asia Pacific newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held 32.3% share of the Asia Pacific newborn screening market in 2022, amassing US$ 87.22 million. It is projected to garner US$ 200.41 million by 2030 to expand at 11.0% CAGR during 2022-2030.

Based on test type, the Asia Pacific newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held 53.7% share of Asia Pacific newborn screening market in 2022, amassing US$ 145.01 million. It is projected to garner US$ 339.70 million by 2030 to expand at 11.2% CAGR during 2022-2030.

By end user, the Asia Pacific newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held 64.8% share of Asia Pacific newborn screening market in 2022, amassing US$ 412.72 million. It is projected to garner US$ 174.92 million by 2030 to expand at 11.3% CAGR during 2022-2030.

Based on country, the Asia Pacific newborn screening market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held 24.9% share of Asia Pacific newborn screening market in 2022, amassing US$ 67.37 million. It is projected to garner US$ 165.18 million by 2030 to expand at 11.9% CAGR during 2022-2030.

Key players operating in the Asia Pacific newborn screening market are Bio-Rad Laboratories Inc, LifeCell International Pvt Ltd, Masimo Corp, Medtronic Plc, Natus Medical Inc, PerkinElmer Inc, Trivitron Healthcare Pvt Ltd, and Waters Corp, among others.

– In May 2023, Masimo launched Stork, a revolutionary home baby monitoring system. This innovative system offers parents insights into their baby’s health data, helping them learn more about and connect better with their baby. The Masimo Stork baby monitor system comprises several components and is available in multiple configurations. Masimo Stork Vitals+, the flagship solution, consists of a boot with a sensor, video camera, and mobile app.

Table 1. Asia Pacific Newborn Screening Market Segmentation
Table 2. Asia Pacific Newborn Screening Market, by Reagents and Assay Kits – Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Newborn Screening Market, by Instruments – Revenue and Forecast to 2030 (US$ Million)
Table 4. China Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. China Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. China Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 7. China Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. China Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. China Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. Japan Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 14. Japan Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. Japan Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 16. India Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 17. India Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. India Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 19. India Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 20. India Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. India Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 23. Australia Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 24. Australia Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 25. Australia Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 26. Australia Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. Australia Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 28. South Korea Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 29. South Korea Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 30. South Korea Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 | (US$ Million)
Table 31. South Korea Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 32. South Korea Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. South Korea Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Asia Pacific Newborn Screening Market, by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Asia Pacific Newborn Screening Market, For Instruments by Product Type – Revenue and Forecast to 2030 (US$ Million)
Table 37. Rest of Asia Pacific Newborn Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 38. Rest of Asia Pacific Newborn Screening Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 39. Rest of Asia Pacific Newborn Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 40. Recent Organic Growth Strategies in Newborn Screening Market
Table 41. Recent Inorganic Growth Strategies in the Newborn Screening Market
Table 42. Glossary of Terms, Newborn Screening Market

Figure 1. Asia Pacific Newborn Screening Market Segmentation, By Country
Figure 2. Newborn Screening Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Newborn Screening Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Asia Pacific Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 6. Reagents and Assay Kits: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Instruments: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 9. Tandem Mass Spectrometry (TMS): Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Molecular Assays: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Immunoassays and Enzymatic Assays: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Other Technologies: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Asia Pacific Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 15. Dry Blood Spot Test: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hearing Screen Test: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Critical Congenital Heart Diseases (CCHD) Test: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Other Test Types: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 20. Hospitals and Clinics: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Diagnostic Laboratories: Asia Pacific Newborn Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific Newborn Screening Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 23. Asia Pacific Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
Figure 24. China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Growth Strategies in Newborn Screening Market